These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26377137)

  • 1. Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.
    Bhatt VR; Loberiza FR; Smith LM; Armitage JO; Greiner TC; Bast M; Lunning MA; Bierman PJ; Vose JM; Bociek RG
    Leuk Lymphoma; 2016; 57(6):1327-34. PubMed ID: 26377137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
    Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
    Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.
    Vogt N; Klapper W
    Histopathology; 2013 Jan; 62(2):334-42. PubMed ID: 23240716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.
    Lee BJ; Liu J; Griffin SP; Doh J; Ciurea SO; Kongtim P; Brem EA
    Cancer Med; 2024 Oct; 13(19):e70310. PubMed ID: 39394843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan.
    Wang YH; Yu SC; Ko BS; Yang YT; Yao M; Tang JL; Huang TC
    Int J Hematol; 2020 Sep; 112(3):385-394. PubMed ID: 32519171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastoid mantle cell lymphoma presenting as acute leukemia: a case report.
    Dongre A; Kanchankar N; Deshmukh M; Wasnik D; Dongre T
    Pan Afr Med J; 2021; 39():150. PubMed ID: 34527166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].
    Ji H; Li GD; Li FY; Bai YQ; Chen Y; Yang MZ; Wang LJ; Tang Y; Zhang P; Xia T; Li C; Feng J; Zou ZK; Yixi JC
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):730-5. PubMed ID: 18307875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
    Gerson JN; Handorf E; Villa D; Gerrie AS; Chapani P; Li S; Medeiros LJ; Wang M; Cohen JB; Churnetski M; Hill BT; Sawalha Y; Hernandez-Ilizaliturri FJ; Kothari S; Vose JM; Bast M; Fenske T; Rao Gari SN; Maddocks KJ; Bond D; Bachanova V; Kolla B; Chavez J; Shah B; Lansigan F; Burns T; Donovan AM; Wagner-Johnston N; Messmer M; Mehta A; Anderson JK; Reddy N; Kovach AE; Landsburg DJ; Glenn M; Inwards DJ; Ristow K; Karmali R; Kaplan JB; Caimi PF; Rajguru S; Evens A; Klein A; Umyarova E; Pulluri B; Amengual JE; Lue JK; Diefenbach C; Fisher RI; Barta SK
    Blood Adv; 2023 Dec; 7(24):7393-7401. PubMed ID: 37874912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
    Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
    Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
    Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
    Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral ocular panadnexal mass as initial presentation of systemic blastoid variant of mantle-cell lymphoma.
    Rašić DM; Knežević M; Terzić T; Vlajković G
    Surv Ophthalmol; 2017; 62(1):83-88. PubMed ID: 27256688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
    Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS
    Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2017 Aug; 92(8):806-813. PubMed ID: 28699667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
    Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
    J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital.
    Bernard M; Tsang RW; Le LW; Hodgson DC; Sun A; Wells W; Kukreti V; Kuruvilla J; Crump M; Gospodarowicz MK
    Leuk Lymphoma; 2013 Feb; 54(2):261-7. PubMed ID: 22793378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
    Avivi I; Goy A
    Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
    Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
    Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.